» Articles » PMID: 20063090

Significant Differences in UK and US Female Bone Density Reference Ranges

Overview
Journal Osteoporos Int
Date 2010 Jan 12
PMID 20063090
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: In the United Kingdom (UK), T- and Z-scores are usually calculated using reference ranges derived from United States (US) populations. In the UK arm of a recent randomised trial (International Breast Cancer Intervention Study II (IBIS-II)), substantially, fewer women than expected were recruited into the osteopenic (-2.5<T-score<-1.0) and osteoporotic (T-score<-2.5) arms of the study. The comparison with data from two independent studies showed that UK women aged >45 years with a typical body mass index of 28 kg m(-2) have spine and hip bone mineral density (BMD) 0.6 standard deviation higher than their US counterparts.

Introduction: Dual energy X-ray absorptiometry (DXA) is widely used for the diagnosis of osteoporosis and to investigate the effect of pharmacological treatments on BMD. In both routine and research settings, it is important that DXA results are correctly interpreted.

Methods: T- and Z-scores for the first 650 UK Caucasian women enrolled in the IBIS-II study were compared with data from two independent studies of unrelated, unselected UK Caucasian women: (1) 2,382 women aged 18 to 79 recruited to the Twins UK Adult Twin Registry; (2) 431 women aged 21 to 84 with no risk factors for osteoporosis recruited at Guy's Hospital. All DXA measurements were performed on Hologic densitometers. Subjects were divided into six age bands, and T- and Z-scores were calculated using the manufacturer's US reference range for the spine and the National Health and Nutrition Examination Survey III reference range for the femoral neck and total hip.

Results: The overall mean Z-scores for the IBIS-II, Twin, and Guy's groups were: spine: +0.61, +0.29, +0.33; femoral neck: +0.42, +0.36, +0.45; total hip: +0.65, +0.38, +0.39 (all p<0.001 compared with the expected value of 0). The mean body weight of subjects in the three studies was 74.4, 65.5, and 65.4 kg, respectively. Analysis revealed a highly significant relationship between Z-score and weight at each BMD site with a slope of 0.03 kg(-1).

Conclusions: In general, US spine and hip reference ranges are not suitable for the calculation of Z-scores in UK women. For some research study designs, the differences may significantly influence the pattern of subject recruitment.

Citing Articles

Age- and Sex-Related Volumetric Density Differences in Trabecular and Cortical Bone of the Proximal Femur in Healthy Population.

Brance M, Saravi F, Henriquez M, Larroude M, Jacobo J, Araujo S J Bone Metab. 2024; 31(4):279-289.

PMID: 39701108 PMC: 11658838. DOI: 10.11005/jbm.24.765.


Reference values for bone density and bone mineral content from 5 to 80 years old in a province of Chile.

Cossio-Bolanos M, Vidal-Espinoza R, Fuentes-Lopez J, Castelli Correia de Campos L, Andruske C, Urra-Albornoz C PeerJ. 2022; 10:e13092.

PMID: 35345584 PMC: 8957281. DOI: 10.7717/peerj.13092.


Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience.

Bischof E, Schwab F, Georgescu Margarint E, Montavon C, Zunti I, Schollbach A Bone Rep. 2022; 16:101160.

PMID: 34977282 PMC: 8685978. DOI: 10.1016/j.bonr.2021.101160.


The Impact of GE Lunar vs ICMR Database in Diagnosis of Osteoporosis among South Indian Subjects.

Balachandran K, Asirvatham A, Mahadevan S Indian J Endocrinol Metab. 2019; 23(5):525-528.

PMID: 31803591 PMC: 6873249. DOI: 10.4103/ijem.IJEM_142_19.


Vitamin D supplementation in breastfed infants from Montréal, Canada: 25-hydroxyvitamin D and bone health effects from a follow-up study at 3 years of age.

Gallo S, Hazell T, Vanstone C, Agellon S, Jones G, Labbe M Osteoporos Int. 2016; 27(8):2459-66.

PMID: 26968165 DOI: 10.1007/s00198-016-3549-z.


References
1.
Meunier P, Roux C, Seeman E, Ortolani S, Badurski J, Spector T . The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004; 350(5):459-68. DOI: 10.1056/NEJMoa022436. View

2.
Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J . Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007; 356(18):1809-22. DOI: 10.1056/NEJMoa067312. View

3.
Lunt M, Felsenberg D, Adams J, Benevolenskaya L, Cannata J, Dequeker J . Population-based geographic variations in DXA bone density in Europe: the EVOS Study. European Vertebral Osteoporosis. Osteoporos Int. 1997; 7(3):175-89. DOI: 10.1007/BF01622286. View

4.
Kaptoge S, da Silva J, Brixen K, Reid D, Kroger H, Nielsen T . Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. Bone. 2008; 43(2):332-339. DOI: 10.1016/j.bone.2008.04.001. View

5.
De Laet C, Kanis J, Oden A, Johanson H, Johnell O, Delmas P . Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005; 16(11):1330-8. DOI: 10.1007/s00198-005-1863-y. View